Global Noninvasive Vaccination Market Insights, Forecast to 2029

Global Noninvasive Vaccination Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Noninvasive Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global Noninvasive Vaccination Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Market by Application
1.3.1 Global Noninvasive Vaccination Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Noninvasive Vaccination Sales Estimates and Forecasts 2018-2029
2.2 Global Noninvasive Vaccination Revenue by Region
2.2.1 Global Noninvasive Vaccination Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Noninvasive Vaccination Revenue by Region (2018-2023)
2.2.3 Global Noninvasive Vaccination Revenue by Region (2024-2029)
2.2.4 Global Noninvasive Vaccination Revenue Market Share by Region (2018-2029)
2.3 Global Noninvasive Vaccination Sales Estimates and Forecasts 2018-2029
2.4 Global Noninvasive Vaccination Sales by Region
2.4.1 Global Noninvasive Vaccination Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Noninvasive Vaccination Sales by Region (2018-2023)
2.4.3 Global Noninvasive Vaccination Sales by Region (2024-2029)
2.4.4 Global Noninvasive Vaccination Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Noninvasive Vaccination Sales by Manufacturers
3.1.1 Global Noninvasive Vaccination Sales by Manufacturers (2018-2023)
3.1.2 Global Noninvasive Vaccination Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Noninvasive Vaccination in 2022
3.2 Global Noninvasive Vaccination Revenue by Manufacturers
3.2.1 Global Noninvasive Vaccination Revenue by Manufacturers (2018-2023)
3.2.2 Global Noninvasive Vaccination Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Noninvasive Vaccination Revenue in 2022
3.3 Global Key Players of Noninvasive Vaccination, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Noninvasive Vaccination Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Noninvasive Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Noninvasive Vaccination, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Noninvasive Vaccination, Product Offered and Application
3.8 Global Key Manufacturers of Noninvasive Vaccination, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Noninvasive Vaccination Sales by Type
4.1.1 Global Noninvasive Vaccination Historical Sales by Type (2018-2023)
4.1.2 Global Noninvasive Vaccination Forecasted Sales by Type (2024-2029)
4.1.3 Global Noninvasive Vaccination Sales Market Share by Type (2018-2029)
4.2 Global Noninvasive Vaccination Revenue by Type
4.2.1 Global Noninvasive Vaccination Historical Revenue by Type (2018-2023)
4.2.2 Global Noninvasive Vaccination Forecasted Revenue by Type (2024-2029)
4.2.3 Global Noninvasive Vaccination Revenue Market Share by Type (2018-2029)
4.3 Global Noninvasive Vaccination Price by Type
4.3.1 Global Noninvasive Vaccination Price by Type (2018-2023)
4.3.2 Global Noninvasive Vaccination Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Noninvasive Vaccination Sales by Application
5.1.1 Global Noninvasive Vaccination Historical Sales by Application (2018-2023)
5.1.2 Global Noninvasive Vaccination Forecasted Sales by Application (2024-2029)
5.1.3 Global Noninvasive Vaccination Sales Market Share by Application (2018-2029)
5.2 Global Noninvasive Vaccination Revenue by Application
5.2.1 Global Noninvasive Vaccination Historical Revenue by Application (2018-2023)
5.2.2 Global Noninvasive Vaccination Forecasted Revenue by Application (2024-2029)
5.2.3 Global Noninvasive Vaccination Revenue Market Share by Application (2018-2029)
5.3 Global Noninvasive Vaccination Price by Application
5.3.1 Global Noninvasive Vaccination Price by Application (2018-2023)
5.3.2 Global Noninvasive Vaccination Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Noninvasive Vaccination Market Size by Type
6.1.1 US & Canada Noninvasive Vaccination Sales by Type (2018-2029)
6.1.2 US & Canada Noninvasive Vaccination Revenue by Type (2018-2029)
6.2 US & Canada Noninvasive Vaccination Market Size by Application
6.2.1 US & Canada Noninvasive Vaccination Sales by Application (2018-2029)
6.2.2 US & Canada Noninvasive Vaccination Revenue by Application (2018-2029)
6.3 US & Canada Noninvasive Vaccination Market Size by Country
6.3.1 US & Canada Noninvasive Vaccination Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Noninvasive Vaccination Sales by Country (2018-2029)
6.3.3 US & Canada Noninvasive Vaccination Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Noninvasive Vaccination Market Size by Type
7.1.1 Europe Noninvasive Vaccination Sales by Type (2018-2029)
7.1.2 Europe Noninvasive Vaccination Revenue by Type (2018-2029)
7.2 Europe Noninvasive Vaccination Market Size by Application
7.2.1 Europe Noninvasive Vaccination Sales by Application (2018-2029)
7.2.2 Europe Noninvasive Vaccination Revenue by Application (2018-2029)
7.3 Europe Noninvasive Vaccination Market Size by Country
7.3.1 Europe Noninvasive Vaccination Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Noninvasive Vaccination Sales by Country (2018-2029)
7.3.3 Europe Noninvasive Vaccination Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Noninvasive Vaccination Market Size
8.1.1 China Noninvasive Vaccination Sales (2018-2029)
8.1.2 China Noninvasive Vaccination Revenue (2018-2029)
8.2 China Noninvasive Vaccination Market Size by Application
8.2.1 China Noninvasive Vaccination Sales by Application (2018-2029)
8.2.2 China Noninvasive Vaccination Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Noninvasive Vaccination Market Size by Type
9.1.1 Asia Noninvasive Vaccination Sales by Type (2018-2029)
9.1.2 Asia Noninvasive Vaccination Revenue by Type (2018-2029)
9.2 Asia Noninvasive Vaccination Market Size by Application
9.2.1 Asia Noninvasive Vaccination Sales by Application (2018-2029)
9.2.2 Asia Noninvasive Vaccination Revenue by Application (2018-2029)
9.3 Asia Noninvasive Vaccination Sales by Region
9.3.1 Asia Noninvasive Vaccination Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Noninvasive Vaccination Revenue by Region (2018-2029)
9.3.3 Asia Noninvasive Vaccination Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Noninvasive Vaccination Market Size by Type
10.1.1 Middle East, Africa and Latin America Noninvasive Vaccination Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Noninvasive Vaccination Market Size by Application
10.2.1 Middle East, Africa and Latin America Noninvasive Vaccination Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Noninvasive Vaccination Sales by Country
10.3.1 Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Noninvasive Vaccination Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 GSK Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Sanofi Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Company Information
11.4.2 Lanzhou Institute Overview
11.4.3 Lanzhou Institute Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Lanzhou Institute Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lanzhou Institute Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Company Information
11.5.2 Serum Institute Overview
11.5.3 Serum Institute Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Serum Institute Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute Recent Developments
11.6 Valneva
11.6.1 Valneva Company Information
11.6.2 Valneva Overview
11.6.3 Valneva Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Valneva Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Valneva Recent Developments
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Company Information
11.7.2 Shanghai United Cell Overview
11.7.3 Shanghai United Cell Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Shanghai United Cell Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai United Cell Recent Developments
11.8 Bibcol
11.8.1 Bibcol Company Information
11.8.2 Bibcol Overview
11.8.3 Bibcol Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bibcol Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bibcol Recent Developments
11.9 PaxVax
11.9.1 PaxVax Company Information
11.9.2 PaxVax Overview
11.9.3 PaxVax Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 PaxVax Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PaxVax Recent Developments
11.10 Vabiotech
11.10.1 Vabiotech Company Information
11.10.2 Vabiotech Overview
11.10.3 Vabiotech Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Vabiotech Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vabiotech Recent Developments
11.11 Tiantan Biological
11.11.1 Tiantan Biological Company Information
11.11.2 Tiantan Biological Overview
11.11.3 Tiantan Biological Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Tiantan Biological Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tiantan Biological Recent Developments
11.12 EuBiologics
11.12.1 EuBiologics Company Information
11.12.2 EuBiologics Overview
11.12.3 EuBiologics Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 EuBiologics Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EuBiologics Recent Developments
11.13 Panacea Biotec Ltd
11.13.1 Panacea Biotec Ltd Company Information
11.13.2 Panacea Biotec Ltd Overview
11.13.3 Panacea Biotec Ltd Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Panacea Biotec Ltd Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Panacea Biotec Ltd Recent Developments
11.14 Bio-Med
11.14.1 Bio-Med Company Information
11.14.2 Bio-Med Overview
11.14.3 Bio-Med Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Bio-Med Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bio-Med Recent Developments
11.15 Halfkin Bio-Pharmaceuticals
11.15.1 Halfkin Bio-Pharmaceuticals Company Information
11.15.2 Halfkin Bio-Pharmaceuticals Overview
11.15.3 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
11.16 AstraZeneca
11.16.1 AstraZeneca Company Information
11.16.2 AstraZeneca Overview
11.16.3 AstraZeneca Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 AstraZeneca Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 AstraZeneca Recent Developments
11.17 Cipla
11.17.1 Cipla Company Information
11.17.2 Cipla Overview
11.17.3 Cipla Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Cipla Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cipla Recent Developments
11.18 BCHT
11.18.1 BCHT Company Information
11.18.2 BCHT Overview
11.18.3 BCHT Noninvasive Vaccination Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 BCHT Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 BCHT Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Noninvasive Vaccination Industry Chain Analysis
12.2 Noninvasive Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Noninvasive Vaccination Production Mode & Process
12.4 Noninvasive Vaccination Sales and Marketing
12.4.1 Noninvasive Vaccination Sales Channels
12.4.2 Noninvasive Vaccination Distributors
12.5 Noninvasive Vaccination Customers
13 Market Dynamics
13.1 Noninvasive Vaccination Industry Trends
13.2 Noninvasive Vaccination Market Drivers
13.3 Noninvasive Vaccination Market Challenges
13.4 Noninvasive Vaccination Market Restraints
14 Key Findings in The Global Noninvasive Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Noninvasive Vaccination Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral Vaccine
Table 3. Major Manufacturers of Nasal Spray Vaccine
Table 4. Global Noninvasive Vaccination Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Noninvasive Vaccination Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Noninvasive Vaccination Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Noninvasive Vaccination Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Noninvasive Vaccination Revenue Market Share by Region (2018-2023)
Table 9. Global Noninvasive Vaccination Revenue Market Share by Region (2024-2029)
Table 10. Global Noninvasive Vaccination Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Noninvasive Vaccination Sales by Region (2018-2023) & (Units)
Table 12. Global Noninvasive Vaccination Sales by Region (2024-2029) & (Units)
Table 13. Global Noninvasive Vaccination Sales Market Share by Region (2018-2023)
Table 14. Global Noninvasive Vaccination Sales Market Share by Region (2024-2029)
Table 15. Global Noninvasive Vaccination Sales by Manufacturers (2018-2023) & (Units)
Table 16. Global Noninvasive Vaccination Sales Share by Manufacturers (2018-2023)
Table 17. Global Noninvasive Vaccination Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Noninvasive Vaccination Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Noninvasive Vaccination, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Noninvasive Vaccination Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Noninvasive Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Noninvasive Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Vaccination as of 2022)
Table 23. Global Key Manufacturers of Noninvasive Vaccination, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Noninvasive Vaccination, Product Offered and Application
Table 25. Global Key Manufacturers of Noninvasive Vaccination, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Noninvasive Vaccination Sales by Type (2018-2023) & (Units)
Table 28. Global Noninvasive Vaccination Sales by Type (2024-2029) & (Units)
Table 29. Global Noninvasive Vaccination Sales Share by Type (2018-2023)
Table 30. Global Noninvasive Vaccination Sales Share by Type (2024-2029)
Table 31. Global Noninvasive Vaccination Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Noninvasive Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Noninvasive Vaccination Revenue Share by Type (2018-2023)
Table 34. Global Noninvasive Vaccination Revenue Share by Type (2024-2029)
Table 35. Noninvasive Vaccination Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Noninvasive Vaccination Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Noninvasive Vaccination Sales by Application (2018-2023) & (Units)
Table 38. Global Noninvasive Vaccination Sales by Application (2024-2029) & (Units)
Table 39. Global Noninvasive Vaccination Sales Share by Application (2018-2023)
Table 40. Global Noninvasive Vaccination Sales Share by Application (2024-2029)
Table 41. Global Noninvasive Vaccination Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Noninvasive Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Noninvasive Vaccination Revenue Share by Application (2018-2023)
Table 44. Global Noninvasive Vaccination Revenue Share by Application (2024-2029)
Table 45. Noninvasive Vaccination Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Noninvasive Vaccination Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Noninvasive Vaccination Sales by Type (2018-2023) & (Units)
Table 48. US & Canada Noninvasive Vaccination Sales by Type (2024-2029) & (Units)
Table 49. US & Canada Noninvasive Vaccination Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Noninvasive Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Noninvasive Vaccination Sales by Application (2018-2023) & (Units)
Table 52. US & Canada Noninvasive Vaccination Sales by Application (2024-2029) & (Units)
Table 53. US & Canada Noninvasive Vaccination Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Noninvasive Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Noninvasive Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Noninvasive Vaccination Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Noninvasive Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Noninvasive Vaccination Sales by Country (2018-2023) & (Units)
Table 59. US & Canada Noninvasive Vaccination Sales by Country (2024-2029) & (Units)
Table 60. Europe Noninvasive Vaccination Sales by Type (2018-2023) & (Units)
Table 61. Europe Noninvasive Vaccination Sales by Type (2024-2029) & (Units)
Table 62. Europe Noninvasive Vaccination Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Noninvasive Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Noninvasive Vaccination Sales by Application (2018-2023) & (Units)
Table 65. Europe Noninvasive Vaccination Sales by Application (2024-2029) & (Units)
Table 66. Europe Noninvasive Vaccination Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Noninvasive Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Noninvasive Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Noninvasive Vaccination Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Noninvasive Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Noninvasive Vaccination Sales by Country (2018-2023) & (Units)
Table 72. Europe Noninvasive Vaccination Sales by Country (2024-2029) & (Units)
Table 73. China Noninvasive Vaccination Sales by Type (2018-2023) & (Units)
Table 74. China Noninvasive Vaccination Sales by Type (2024-2029) & (Units)
Table 75. China Noninvasive Vaccination Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Noninvasive Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Noninvasive Vaccination Sales by Application (2018-2023) & (Units)
Table 78. China Noninvasive Vaccination Sales by Application (2024-2029) & (Units)
Table 79. China Noninvasive Vaccination Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Noninvasive Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Noninvasive Vaccination Sales by Type (2018-2023) & (Units)
Table 82. Asia Noninvasive Vaccination Sales by Type (2024-2029) & (Units)
Table 83. Asia Noninvasive Vaccination Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Noninvasive Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Noninvasive Vaccination Sales by Application (2018-2023) & (Units)
Table 86. Asia Noninvasive Vaccination Sales by Application (2024-2029) & (Units)
Table 87. Asia Noninvasive Vaccination Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Noninvasive Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Noninvasive Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Noninvasive Vaccination Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Noninvasive Vaccination Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Noninvasive Vaccination Sales by Region (2018-2023) & (Units)
Table 93. Asia Noninvasive Vaccination Sales by Region (2024-2029) & (Units)
Table 94. Middle East, Africa and Latin America Noninvasive Vaccination Sales by Type (2018-2023) & (Units)
Table 95. Middle East, Africa and Latin America Noninvasive Vaccination Sales by Type (2024-2029) & (Units)
Table 96. Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Noninvasive Vaccination Sales by Application (2018-2023) & (Units)
Table 99. Middle East, Africa and Latin America Noninvasive Vaccination Sales by Application (2024-2029) & (Units)
Table 100. Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Noninvasive Vaccination Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Noninvasive Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Noninvasive Vaccination Sales by Country (2018-2023) & (Units)
Table 106. Middle East, Africa and Latin America Noninvasive Vaccination Sales by Country (2024-2029) & (Units)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Merck Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. GSK Company Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. GSK Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GSK Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Sanofi Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Lanzhou Institute Company Information
Table 123. Lanzhou Institute Description and Major Businesses
Table 124. Lanzhou Institute Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Lanzhou Institute Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lanzhou Institute Recent Developments
Table 127. Serum Institute Company Information
Table 128. Serum Institute Description and Major Businesses
Table 129. Serum Institute Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Serum Institute Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Serum Institute Recent Developments
Table 132. Valneva Company Information
Table 133. Valneva Description and Major Businesses
Table 134. Valneva Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Valneva Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Valneva Recent Developments
Table 137. Shanghai United Cell Company Information
Table 138. Shanghai United Cell Description and Major Businesses
Table 139. Shanghai United Cell Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Shanghai United Cell Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Shanghai United Cell Recent Developments
Table 142. Bibcol Company Information
Table 143. Bibcol Description and Major Businesses
Table 144. Bibcol Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Bibcol Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bibcol Recent Developments
Table 147. PaxVax Company Information
Table 148. PaxVax Description and Major Businesses
Table 149. PaxVax Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. PaxVax Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. PaxVax Recent Developments
Table 152. Vabiotech Company Information
Table 153. Vabiotech Description and Major Businesses
Table 154. Vabiotech Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. Vabiotech Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Vabiotech Recent Developments
Table 157. Tiantan Biological Company Information
Table 158. Tiantan Biological Description and Major Businesses
Table 159. Tiantan Biological Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. Tiantan Biological Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Tiantan Biological Recent Developments
Table 162. EuBiologics Company Information
Table 163. EuBiologics Description and Major Businesses
Table 164. EuBiologics Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. EuBiologics Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. EuBiologics Recent Developments
Table 167. Panacea Biotec Ltd Company Information
Table 168. Panacea Biotec Ltd Description and Major Businesses
Table 169. Panacea Biotec Ltd Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. Panacea Biotec Ltd Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Panacea Biotec Ltd Recent Developments
Table 172. Bio-Med Company Information
Table 173. Bio-Med Description and Major Businesses
Table 174. Bio-Med Noninvasive Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Bio-Med Noninvasive Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Bio-Med Recent Developments
Table 177. Halfkin Bio-Pharmaceuticals Company Information
Table 178. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 179. Halfkin Bio-Pharmace

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs